Nov 09, 2022 / 07:35PM GMT
Albert J. William Rice - Crédit Suisse AG - Research Division - Research Analyst
(technical difficulty)
these things out, asking people to talk a little bit about the wins for the year and some of the challenges. And you guys are focused particularly on the commercial side. So I might ask you that, and Steve can chime in if he wants on something more broadly. But is that all right, Morgan?
Questions and Answers:
Charles Morgan Kendrick - Elevance Health Inc. - Executive VP and President of Commercial & Specialty Business DivisionThat's perfectly fine. No, A.J., thank you for having us. It's a pleasure to be with everybody. And yes, this year, actually, it's -- we're finishing up '22, which we started out remarkably well from a growth perspective, notably on the upper end of our fee-based business, both in large group local business as well as our national markets.
We've also concluded the '23 cycle as it relates to the national business, and we certainly know that -- we've talked about it a bit. It's been
Trustpilot
